Exane BNP Paribas is a top-ten broker for European equities, bolstered by the expansion of a strong platform in London, which was the engine behind the group's European strategy.
Exane BNP Paribas's 115 analysts cover about 600 European stocks (75% of which are non-French), and work closely with a 120 sales and sales-trading team. The group thus benefits from critical mass and acknowledged expertise in this business line, in which it continues to pursue a sustained and ambitious investment policy.
Exane BNP Paribas serves more than 1,200 institutional investors worldwide from a base of 9 offices (Paris, London, Frankfurt, Geneva, Madrid, Milan, Stockholm, New York and Singapore).
Continued investment in both research and execution
Exane BNP Paribas's sound and balanced model is based on:
- Independent, fundamental Pan-European company and industry research.
- Analysts have worked within the industries they follow. Rigorous financial analysis underpins their qualitative work.
- Experienced sales teams located locally in all the major financial centres globally, led by London, Paris and New York.
- A comprehensive range of execution services: high-touch sales trading, facilitation, electronic trading, program trading and ETFs.
An innovative partnership with BNP Paribas
Since 2004 the cash equities business has been underpinned by an operational partnership with BNP Paribas under which Exane has exclusivity on European equities in this segment under the Exane BNP Paribas brand.
Under this agreement, Exane BNP Paribas lends its expertise in equity research to BNP Paribas' business lines. The two groups also collaborate closely on ECM (Equity Capital Market) transactions, with BNP Paribas handling origination and Exane BNP Paribas distribution.
This balanced partnership has enhanced Exane's strength in the cash equities business, enabling it to accelerate its growth in Europe and sustain its investment strategy throughout the cycle, while still preserving its independence.